Melanoma cell invasive and metastatic potential correlates with endothelial cell reorganization and tenascin expression

Endothelium: Journal of Endothelial Cell Research

Volumn 4, Issue 2, 1996, Pages 85-97

  Sriramarao, P ^a   Bourdon, Mario A ^a  

^a La Jolla Institute for Experimental Medicine   (United States)

Author keywords

Adhesion; Angiogenesis; Endothelial cells; Integrins; Tenascin

Indexed keywords

FIBRONECTIN; LAMININ; MATRIX PROTEIN; TENASCIN;

ARTICLE; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FETUS; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS POTENTIAL; NORMAL HUMAN; UMBILICAL VEIN;

EID: 0029961132     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.3109/10623329609024685     Document Type: Article

References (36)

1. Albelda, S. M., Daise, M., Levine, E. M. and Buck, C. A. (1989). Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J. Clin. Invest., 83, 1992-2002.
2. Augustin-Voss, H. G., and Pauli, B. A. (1992). Quantitative analysis of autocrine-regulated, matrix-induced, and tumor cell-stimulated endothelial cell migration using silicone template compartmentalization technique. Exp. Cell Res., 198, 221-227.
3. Basson, C. T., Knowles, W. J., Bell, L., Albelda, S. M., Castronovo, V., Liotta, L. A. and Madri, J. A. (1990). Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding during adhesion events. J. Cell Biol., 110, 789-801.
4. Bourdon, M. A., Wilkstrand, C. J., Furthmayer, H., Matthews, T. J. and Bigner, D. D. (1983). Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res., 43, 2796-2805.
5. Bourdon, M. A., Coleman, R. E., Blasberg, R. G., Groothius, D. R. and Bigner, D. D. (1984). Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis. Anticancer Res., 4, 133-140.
6. Bourdon, M. A., Matthews, T. J., Pizzo, S. V. and Bigner, D. D. (1985). Immunochemical and biochemical characterization of a glioma-associated extracellular matrix glycoprotein. J. Cell. Biochem., 28, 183-195.
7. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157-1164.
8. Chiquet-Ehrismann, R. (1990). What distinguishes tenascin from fibronectin. FASEB J., 4, 2598-2604.
9. Daniloff, J. K., Crossin, K. L., Pincon-Raymond, M., Murawsky, M., Rieger, F. and Edelman, G. M. (1989). Expression of cytotactin in the normal and regenerating neuromuscular system. J. Cell Biol., 108, 625-635.
10. Ekblom, P. and Aufderheide, E. (1989). Stimulation of tenascin in mesenchyme by epithelial-mesenchymal interactions. Int. J. Dev. Biol., 33, 71-79.
11. Erickson, H. P. and Bourdon, M. A. (1989). Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann. Rev. Cell Biol., 5, 71-92.
12. Erickson, H. P. and Lightner, V. A. (1988). Hexabrachion protein (tenascin, cytotactin, branchionectin) in connective tissues, embryonic brain, and tumors. Adv. Cell Biol., 2, 55-90.
13. Gehlsen, K. R., Davis, G. E. and Sriramarao, P. (1992). Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. Exp. Metastasis, 10, 111-120.
14. Gimbrone, M. A. (1976). Culture of vascular endothelium. Prog. Hemostasis Thromb., 3, 1-28.
15. Goldblum, S. E., Ding, X., Funk, S. E. and Sage, E. H. (1994). SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc. Natl. Acad. Sci. USA., 91, 3448-3452.
16. Grumet, M., Milev, P., Sakurai, T., Karthikeyan, L., Bourdon, M. A., Margolis, R. K. and Margolis, R. U. (1994). Interaction with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chodritin sulfate proteoglycans of nervous tissue. J. Biol Chem., 269, 12142-12146.
17. Gulcher, J. R., Nies, D. E., Marton, L. S. and Stefansson, K. (1989). An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc. Natl. Acad. Sci. USA., 86, 1588-1592.
18. Halfter, W., Chiquet-Ehrismann, R. and Tucker, R. P. (1989). The effect of TN and embryonic basal lamina on the behaviour and morphology of neural crest cells in vitro. Dev. Biol., 132, 14-25.
19. Joshi, P., Chung, C.-Y., Aukhil, I. and Erickson, H. P. (1993). Endothelial cells adhere to the RGD domain and fibrinogen-like terminal knob of tenascin. J. Cell Science, 106, 389-100.
20. Kozlowski, J. M., Hart, I. R., Fidler, I. J. and Hana, N. (1984). A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Can. Inst., 72, 913-917.
21. Lampugnani, M. G., Resnati, M., Dejana, E. and Marchiso, P. C. (1991). The role of integrins in the maintenance of endothelial monolayer integrity. J. Cell Biol., 112, 479-190.
22. Lochter, A., Vaughan, L., Kaplony, A., Prochiantz, A., Schachner, M. and Faissner, A. (1991). J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite out-growth. J. Cell Biol., 113, 1159-1171.
23. Mackie, E. J., Halfter, W. and Liverani, D. (1988a). Induction of tenascin in healing wounds. J. Cell Biol., 107, 2757-2767.
24. Mackie, E. J., Tucker, R. P., Halfter, W., Chiquet-Ehrisman, R. and Epperlein, H. H. (1988b). The distribution of tenascin coincides with pathways of neural crest cell migration. Development, 102, 237-350.
25. Madri, J. A., Dreyer, B., Pitlick, P. A. and Furthmayr, H. (1980). The collagenous components of the subendothelium: correlation of structure and function. Lab. Invest., 43, 303-315.
26. Madri, J. A., Pratt, B. M. and Yannariello-Brown, J. (1988). Matrix driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am. J. Pathol., 132, 18-27.
27. Murphy-Ullrich, J. E., Lightner, V. A., Aukhil, I., Yan, Y. Z., Erickson, H. P. and Hook, M. (1991). Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J. Cell Biol., 115, 1127-1136.
28. Murphy-Ullrich, J. E. and Hook, M. (1989). Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol., 109, 1309-1319.
29. Rosen, E. M., Carley, W. and Goldberg, I. D. (1990). Scatter factor regulates vascular endothelial cell motility. Cancer Invest., 8, 647-650.
30. Sriramarao, P. and Bourdon, M. A. (1993). A novel tenascin type III repeat is a complex of a tenascin mRNA alternative splices. Nucleic Acids Res., 21, 163-168.
31. 3 integrins. J. Cell Sci. 105: 1001-1012.
32. Thornton, S. C., Mueller, S. N. and Levine, E. M. (1983). Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science Wash. DC, 222, 623-625.
33. Vrucinic-Filipi, N. and Chiquet-Ehrismann, R. (1993). Tenascin function and regulation of expression. Symp. Soc. Exp. Biol., 47, 155-162.
34. Vogel, T., Guo, N. H., Krutzsch, H. C., Blake, D. A., Hartman, J., Mendelovitz, S., Panet, A. and Roberts, D. D. (1993). Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I thrombospondin. J. Cell Biochem., 53, 74-84.
35. Wehrle, B. and Chiquet, M. (1990). Tenascin is accumulated along developing peripheral nerves and allows neurite out-growth in vitro. Development, 110, 401-415.
36. Wehrle, B. and Chiquet, M. (1993). Dual function of tenascin: simultaneous promotion of neurite outgrowth and inhibition of glial migration. J. Cell Sci., 106, 597-610.